IL161163A0 - Anthranilic acid amides and pharmaceutical use thereof - Google Patents

Anthranilic acid amides and pharmaceutical use thereof

Info

Publication number
IL161163A0
IL161163A0 IL16116302A IL16116302A IL161163A0 IL 161163 A0 IL161163 A0 IL 161163A0 IL 16116302 A IL16116302 A IL 16116302A IL 16116302 A IL16116302 A IL 16116302A IL 161163 A0 IL161163 A0 IL 161163A0
Authority
IL
Israel
Prior art keywords
acid amides
pharmaceutical use
anthranilic acid
anthranilic
pharmaceutical
Prior art date
Application number
IL16116302A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL161163A0 publication Critical patent/IL161163A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
IL16116302A 2001-11-08 2002-11-07 Anthranilic acid amides and pharmaceutical use thereof IL161163A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0126901.8A GB0126901D0 (en) 2001-11-08 2001-11-08 Organic compounds
GBGB0212917.9A GB0212917D0 (en) 2001-11-08 2002-06-05 Organic compounds
PCT/EP2002/012445 WO2003040101A1 (en) 2001-11-08 2002-11-07 Anthranilic acid amides and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
IL161163A0 true IL161163A0 (en) 2004-08-31

Family

ID=26246753

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16116302A IL161163A0 (en) 2001-11-08 2002-11-07 Anthranilic acid amides and pharmaceutical use thereof

Country Status (25)

Country Link
US (1) US7067543B2 (de)
EP (2) EP2269988B1 (de)
JP (1) JP4179989B2 (de)
KR (1) KR100633814B1 (de)
CN (1) CN100467450C (de)
AR (1) AR037261A1 (de)
AT (1) ATE494278T1 (de)
AU (1) AU2002342889B2 (de)
BR (1) BR0213939A (de)
CA (1) CA2462390C (de)
DE (1) DE60238856D1 (de)
GB (2) GB0126901D0 (de)
HR (1) HRP20040412A2 (de)
IL (1) IL161163A0 (de)
MX (1) MXPA04004390A (de)
MY (1) MY136322A (de)
NO (1) NO326986B1 (de)
NZ (1) NZ532587A (de)
PE (1) PE20030540A1 (de)
PL (1) PL368417A1 (de)
PT (1) PT1446381E (de)
RS (1) RS29404A (de)
RU (1) RU2315756C2 (de)
TW (1) TWI260985B (de)
WO (1) WO2003040101A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7307088B2 (en) * 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
GB0229022D0 (en) * 2002-12-12 2003-01-15 Novartis Ag Organic Compounds
UA89035C2 (ru) 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
KR100904360B1 (ko) 2004-01-28 2009-06-23 미쓰이 가가쿠 가부시키가이샤 아미드 유도체 및 그 제조 방법 및 그의 살충제로서의 사용방법
DE102004009238A1 (de) * 2004-02-26 2005-09-08 Merck Patent Gmbh Arylamid-Derivate
WO2006070878A1 (ja) * 2004-12-28 2006-07-06 Astellas Pharma Inc. カルボン酸誘導体またはその塩
EP2145873A1 (de) * 2008-06-17 2010-01-20 Commissariat A L'energie Atomique Neue Verbindungen, die eine Schutzaktivität gegen die Wirkung von Toxinen und Viren über einen intrazellulären Wirkungsmechanismus entfalten
NZ591820A (en) 2008-08-27 2012-12-21 Leo Pharma As Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3226394A (en) * 1964-06-16 1965-12-28 Shulton Inc Pyridylethylated anthranilamides and derivatives thereof
WO1998014449A1 (en) 1996-10-02 1998-04-09 Novartis Ag Fused pyrazole derivatives and processes for their preparation
GB9824579D0 (en) * 1998-11-10 1999-01-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60238856D1 (de) 2011-02-17
WO2003040101A1 (en) 2003-05-15
NO326986B1 (no) 2009-03-30
CN1578768A (zh) 2005-02-09
CA2462390A1 (en) 2003-05-15
RU2315756C2 (ru) 2008-01-27
TW200300086A (en) 2003-05-16
BR0213939A (pt) 2004-08-31
KR100633814B1 (ko) 2006-10-13
TWI260985B (en) 2006-09-01
AU2002342889B2 (en) 2007-03-01
GB0212917D0 (en) 2002-07-17
RS29404A (en) 2007-02-05
PE20030540A1 (es) 2003-08-05
HRP20040412A2 (en) 2005-06-30
EP2269988B1 (de) 2012-05-23
MXPA04004390A (es) 2005-05-16
US20040248947A1 (en) 2004-12-09
JP4179989B2 (ja) 2008-11-12
AR037261A1 (es) 2004-11-03
KR20050044374A (ko) 2005-05-12
CN100467450C (zh) 2009-03-11
RU2004117548A (ru) 2005-06-10
CA2462390C (en) 2011-01-11
EP1446381A1 (de) 2004-08-18
NZ532587A (en) 2006-02-24
MY136322A (en) 2008-09-30
ATE494278T1 (de) 2011-01-15
JP2005508382A (ja) 2005-03-31
PT1446381E (pt) 2011-01-31
EP2269988A2 (de) 2011-01-05
GB0126901D0 (en) 2002-01-02
EP2269988A3 (de) 2011-02-16
EP1446381B1 (de) 2011-01-05
PL368417A1 (en) 2005-03-21
NO20042137L (no) 2004-05-25
US7067543B2 (en) 2006-06-27

Similar Documents

Publication Publication Date Title
IL158504A (en) Anthranilic acid amides and pharmaceutical preparations thereof
HUP0302845A3 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
AU2003288126A1 (en) Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
NO20012245L (no) Anthranilsyreamider og anvendelse derav som medikamenter
EP1367060A4 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
AU2001274001A1 (en) Ortho-substituted anthranilic acid amides and their use as medicaments
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
IL219310A (en) Anti-micronucleic nucleic acid molecules and their pharmaceutical preparations
IL175480A0 (en) Novel hydroxamic acid esters and pharmaceutical use thereof
SI1411921T2 (sl) Farmacevtski sestavki, ki vsebujejo terbinafin, in njihova uporaba
GB0108470D0 (en) Pharmaceutical compositions and their use
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
IL161163A0 (en) Anthranilic acid amides and pharmaceutical use thereof
AU2002342889A1 (en) Anthranilic acid amides and pharmaceutical use thereof
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
EP1379228A4 (de) (z)-styrylbenzylsulfone und ihre pharmazeutischen anwendungen
EP1407771A4 (de) Sophoridin und seine verwendung als analgetikum
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002210989A1 (en) Cyclopropanecarboxylic acid amide compounds and medicinal use thereof
EP1437363A4 (de) Arzneimitteltransporter und verwendung davon